SML0038

Fluvastatin sodium hydrate

≥98% (HPLC), HMG-CoA reductase inhibitor, powder

• Synonym(e): (±)-(3R^*,5S^*,6E)-7-[3-(4-Fluorophenyl)-1-(1-methyethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid sodium salt hydrate
• Empirische Formel (Hill-System): C₂₄H₂₅FNO₄ · Na · xH₂O
• CAS-Nummer: 93957-55-2
• Molekulargewicht: 433.45 (anhydrous basis)
• UNSPSC Code: 12352204
• PubChem Substance ID: 329825108
• NACRES: NA.77
• MDL number: MFCD20488050
• Assay: ≥98% (HPLC)
• Form: powder
• Storage condition: desiccated

Eigenschaften

• Produktname: Fluvastatin sodium hydrate, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• storage condition: desiccated
• color: white to tan
• solubility: H₂O: ≥9 mg/mL
• originator: Novartis
• storage temp.: 2-8°C
• SMILES string: O.[Na+].CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)c(-c2ccc(F)cc2)c3ccccc13
• InChI: 1S/C24H26FNO4.Na.H2O/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30;;/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30);;1H2/q;+1;/p-1/b12-11+;;/t18-,19-;;/m1../s1
• InChI key: KKEMYLLTGGQWCE-PMRANXHDSA-M

Beschreibung

Application

Fluvastatin sodium hydrate has been used:

• to examine its effect on β -glucan-induced training on immunity
• to investigate the effect of statins on the number of uncoupling protein 1 (UCP1)⁺ cells
• to determine its effect on insulin degrading enzyme (IDE) secretion from astrocytes
• to treat and study its effect on human umbilical vein endothelial cells (HUVECs) in vitro

Fluvastatin sodium hydrate has been used:

• to test its anti-hepatitis C virus (HCV) activity
• as a cholesterol inhibitor
• to study its effects on β-glucan-induced monocyte immune training

Biochem/physiol Actions

Fluvastatin is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Fluvastatin is antilipemic and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.

Fluvastatin has antifungal activity.

Features and Benefits

This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable